404
Nootropics Market Analysis | 2024-2030
Nootropics Market Size, Share, Trends, Dynamics, Forecast, & Growth Analysis: 2024-2030
Nootropics are drugs or supplements that are consumed by sportsmen and adults to enhance memory and other cognitive abilities. These are available in both OTC form and prescription drug type, wherein prescription nootropics are drugs that are used to treat diseases such as ‘attention deficit hyperactivity disorder’ (ADHD), Alzheimer’s disease, and narcolepsy. Whereas non-prescription drugs or OTC do not treat diseases but are consumed for improving brain performance and concentration capabilities.
The nootropics market was estimated at USD 3.7 billion in 2023.
The nootropics market is likely to reach USD 9.66 billion in 2030.
The nootropics market is likely to grow at a CAGR of 14.67% during 2024-2030.
Accelerated Intelligence Inc. (UK), AlternaScript (The U.S), HVMN (The U.S), Onnit Labs, Inc. (The U.S), Peak Nootropics (The U.S), Teva Pharmaceutical Industries (Israel), Purelife Bioscience Co., Ltd. (China), United Pharmacies (Moldova), SupNootropic bio co.,ltd (The U.S) and Powder City (The U.S) are among the top players in the market.
North America dominated the nootropics market in 2023 with an astounding share of more than 40% and is projected to grow at a healthy CAGR during the review period.
Increasing demand for smart drugs and brain boosters, continuous product development using both natural and synthetic raw materials, and the surge in the vegan population in developed countries of Europe and North America are the factors driving the growth of the market.
The online segment held a substantial market share in 2023 and is projected to register a robust CAGR of almost 14% during the review period.